Acadia Healthcare Issues Statement with Respect to Government Investigation
27 Septembre 2024 - 2:30PM
Business Wire
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) issued the
following statement with respect to a government investigation
separately disclosed today by the Company. Acadia is cooperating
fully with the authorities regarding this matter.
“Ensuring we provide the highest quality of care is personal for
me and the number one priority for my colleagues across the
Company,” said Acadia Chief Executive Officer Chris Hunter. “We
take seriously our patient care and compliance responsibilities and
understand how critical it is to provide these services with
excellence and compassion. We’re committed to taking action on
incidents that fall short of our rigorous standards and are making
investments necessary to establish Acadia as the leading behavioral
healthcare provider for high-acuity and complex needs
patients.”
Hunter added, “Over the last two years, we have been investing
in new talent, technology, clinical protocols and training across
all of our service lines to drive forward our culture of caring. We
have also expanded our leadership team to include new roles and
expertise critical to providing even safer, higher-quality care –
our Chief Quality Officer of Inpatient Services, Chief Compliance
Officer, Chief Information Officer, and most recently, our Chief
Medical Officer. It will take time for the benefits of our
initiatives to be fully realized, but we’re already seeing positive
results.”
Recent Media Reports
During the last several weeks, media has reported on patients
who have shared troubling experiences at Acadia’s facilities. As
reported, these experiences are completely inconsistent with
Acadia’s policies and protocols. Furthermore, reporting on these
issues has not reflected the many clinical considerations that
inform the appropriate care for a person facing a mental health
crisis, including whether and for how long they should receive
direct care in a facility.
These are complex medical decisions, and all decisions on
patient care, including whether treatment is necessary and for how
long, are made by licensed physicians, and in accordance with
stringent state, federal and other regulations. At Acadia,
decisions on patient care are not business decisions — they are
medical ones – and these decisions are not in any way related to or
influenced by insurance coverage or a patient’s ability to pay. In
fact, in 2023 alone, Acadia provided millions of dollars in care
for which the Company was not reimbursed by insurance companies,
Medicaid or Medicare, but that Acadia felt was critical to ensuring
the best outcomes for patients.
Actions Underpinning Our Commitment to Care
Acadia is committed to doing everything in its power to ensure
that all patients in Acadia’s care receive the support and
compassionate treatment they deserve, and Acadia is at the
forefront of the industry in initiatives that improve care,
including:
- Expanding the Company’s organizational structure with new
roles critical to providing safe, quality care. For example,
Acadia advanced oversight of its care and safety programs by
splitting Quality and Compliance into two distinct, specialized
teams. Acadia’s Chief Medical Officer and Chief Quality Officer of
Inpatient Services provide direct oversight on patient safety,
clinical quality and regulatory compliance initiatives, while its
Chief Compliance Officer provides direct oversight of Acadia’s
corporate compliance program. Acadia also established new safety
committees at each facility comprised of facility management and
frontline staff to promote quality assurance and continuous
improvement.
- Allocating approximately $100 million in additional
technology investments that enhance patient and staff safety as
well as care coordination, such as electronic medical records (EMR)
systems, a wearable remote patient monitoring system, a
communication and assistance alert device for staff and a
cloud-based performance improvement software solution, all of which
provide greater transparency on all clinical and quality operations
and oversight at Acadia’s facilities.
- Incorporating new field-based training programs for
frontline caregivers – such as milieu management and verbal
de-escalation training – to create a more therapeutic environment
that improves patient experience and enhances clinical
outcomes.
- Standardizing clinical protocols and oversight to
address head-on the fragmentation and variability patients have
historically faced when seeking treatment for life-threatening
behavioral health and substance use disorders.
These actions are already starting to deliver positive results.
For example, more patients have expressed feelings of safety, hope
and healing when rating their care in our facilities; our patient
experience scores have meaningfully increased in just one year; and
across our 161 CTC Opioid Treatment Programs, we scored >99%
against all 13 dimensions of quality as measured by CARF, a leading
accreditation body for behavioral health facilities.
To learn more, visit quality.acadiahealthcare.com.
About Acadia Healthcare
Acadia (NASDAQ: ACHC) is a leading provider of behavioral
healthcare services across the United States. As of June 30, 2024,
Acadia operated a network of 258 behavioral healthcare facilities
with approximately 11,400 beds in 38 states and Puerto Rico. With
approximately 23,500 employees serving more than 75,000 patients
daily, Acadia is the largest stand-alone behavioral healthcare
company in the U.S. Acadia provides behavioral healthcare services
to its patients in a variety of settings, including inpatient
psychiatric hospitals, specialty treatment facilities, residential
treatment centers, and outpatient clinics. For more information,
please visit AcadiaHealthcare.com.
Forward-Looking Information
This press release contains forward-looking statements.
Generally, words such as “may,” “will,” “should,” “could,”
“anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,”
and “believe” or the negative of or other variation on these and
other similar expressions identify forward-looking statements.
These forward-looking statements are made only as of the date of
this press release. We do not undertake to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise. Forward-looking statements are based on
current expectations and involve risks and uncertainties and our
future results could differ significantly from those expressed or
implied by our forward-looking statements. Factors that may cause
actual results to differ materially include, without limitation,
(i) potential difficulties in successfully integrating the
operations of acquired facilities or realizing the expected
benefits and synergies of our facility expansions, acquisitions,
joint ventures and de novo transactions; (ii) Acadia’s ability to
add beds, expand services, enhance marketing programs and improve
efficiencies at its facilities; (iii) potential reductions in
payments received by Acadia from government and commercial payors;
(iv) the occurrence of patient incidents, governmental
investigations, litigation and adverse regulatory actions, which
could adversely affect the price of our common stock and result in
substantial payments and incremental regulatory burdens; (v) the
risk that Acadia may not generate sufficient cash from operations
to service its debt and meet its working capital and capital
expenditure requirements; (vi) potential disruptions to our
information technology systems or a cybersecurity incident; and
(vii) potential operating difficulties, including, without
limitation, disruption to the U.S. economy and financial markets;
reduced admissions and patient volumes; increased costs relating to
labor, supply chain and other expenditures; changes in competition
and client preferences; and general economic or industry conditions
that may prevent Acadia from realizing the expected benefits of its
business strategies. These factors and others are more fully
described in Acadia’s periodic reports and other filings with the
SEC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240926856187/en/
Investor Contact: Patrick Feeley Senior Vice President,
Investor Relations (615) 861-6000
Media Contact: Tim Blair Vice President, Communications
(615) 861-6000
Acadia Healthcare (NASDAQ:ACHC)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Acadia Healthcare (NASDAQ:ACHC)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024